Objective: To study the possible etiological role of MLH1 gene 415G/C polymorphism in sporadic Chinese colorectal cancer (CRC) patients.

Methods: Ninety-seven sporadic CRC patients and 138 normal controls were collected from Hubei Provincial Cancer Hospital and the People's Hospital of Wuhan University. In addition, five CRC families including 6 patients and their 19 first-degree relatives were also recruited. Genomic DNA was extracted from peripheral blood samples. Gene mutation was analyzed by PCR-RFLP. MLH1 mRNA expression in colorectal mucosa was analyzed by RT-PCR.

Results: The frequency of MLH1 gene CC genotype was significantly higher in sporadic CRC patients than that in controls (P=0.035, OR=5.29, 95% CI: 1.07-26.04). In the CRC families, the C allele frequency of CRC patients and their relatives was increased, compared with sporadic CRC patients and normal controls, respectively (P=0.003 and P=0.006). MLH1 mRNA expression of colorectal mucosa was similar in different genotypes.

Conclusion: MLH1 gene 415G/C polymorphism might be a risk factor to sporadic CRC in Chinese. The mutation does not affect the MLH1 mRNA expression. For first-degree relatives from CRC families, carriers of MLH1 415C allele have a high risk to CRC.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2009.03.017DOI Listing

Publication Analysis

Top Keywords

mlh1 gene
16
sporadic crc
16
crc patients
16
gene 415g/c
12
415g/c polymorphism
12
crc families
12
mlh1 mrna
12
mrna expression
12
crc
10
colorectal cancer
8

Similar Publications

Endometrial cancer [EC] is the fourth most common cancer in women in the United States. Stark racial disparities are present in EC outcomes in which Black women have significantly higher EC-related mortality than White women. The social and biologic factors that contribute to these disparities are complex, and may include racial differences in epigenetic landscapes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effectiveness of using two immunohistochemical markers (PMS2 and MSH6) as a replacement for four markers (MLH1, PMS2, MSH2, MSH6) in detecting mismatch repair deficient (dMMR) cancers across nearly 8,000 cases.
  • The results indicated high consistency between the two marker sets, with Cohen κ values ranging from 0.88 to 1.00, and overall sensitivity and specificity for 2-MMR at 99.6% and 100%, respectively.
  • The findings suggest that the more streamlined 2-MMR could effectively replace 4-MMR for dMMR screening due to its high reliability, with only a minuscule
View Article and Find Full Text PDF

In today's world, with its continuing advancements in genetics, the identification of Lynch syndrome (LS) increasingly relies on sophisticated genetic testing techniques. Most guidelines recommend a tailored surveillance program, as well as personalized prophylactic and therapeutic approaches, according to the type of dMMR gene mutation. Carriers of path_MLH1 and path_MSH2 genes have a higher risk of developing colorectal cancer (CRC), despite intensive colonoscopic surveillance.

View Article and Find Full Text PDF

Carcinogenesis encompasses processes that lead to increased mutation rates, enhanced cellular division (tumour growth), and invasive growth. Colorectal cancer (CRC) carcinogenesis in carriers of pathogenic APC (path_APC) and pathogenic mismatch repair gene (path_MMR) variants is initiated by a second hit affecting the corresponding wild-type allele. In path_APC carriers, second hits result in the development of multiple adenomas, with CRC typically emerging after an additional 20 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!